Citing poor sells, Bristol-Myers Squibb said Wednesday that it will stop selling its controversial antidepressant drug Serzone in the United States as of June 14. But critics blame the drug’s risk of liver failure, which has brought many lawsuits against the company, for the withdrawal.
Public Citizen, a consumer advocate group, said the company’s action is […]

A consumer advocacy group on Monday filed a lawsuit against the U.S. Food and Drug Administration over the anti-depressant drug Serzone, which has been linked to a number of deaths and serious injuries from liver failure.
The group, Public Citizen, said it filed the lawsuit because the FDA had failed to act on a petition […]

Toronto law firm Rochon Genova, LLP has filed a class action lawsuit against Bristol-Myers Squibb in Canada on behalf of Steve and Louise Ledyit and all Canadians who have suffered liver damage as a result of taking the antidepressant drug Serzone (nefazodone), which has been linked to liver failure.
Published reports have linked nefazodone hydrochloride […]

Consumer advocacy group Public Citizen submitted a petition to the US Food and Drug Administration urging the agency to remove from the market the popular antidepressant Serzone (nefazodone), manufactured by Bristol-Myers Squibb.
Public Citizen argues that based on adverse reaction reports to the FDA, Serzone, was associated with at least 53 cases of liver injury including […]